These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11427794)

  • 1. [Sarcoidosis: thalidomide treatment in ten patients].
    Estines O; Revuz J; Wolkenstein P; Bressieux JM; Roujeau JC; Cosnes A
    Ann Dermatol Venereol; 2001 May; 128(5):611-3. PubMed ID: 11427794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cutaneous sarcoidosis with thalidomide.
    Nguyen YT; Dupuy A; Cordoliani F; Vignon-Pennamen MD; Lebbé C; Morel P; Rybojad M
    J Am Acad Dermatol; 2004 Feb; 50(2):235-41. PubMed ID: 14726878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement.
    Oliver SJ; Kikuchi T; Krueger JG; Kaplan G
    Clin Immunol; 2002 Mar; 102(3):225-36. PubMed ID: 11890709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids.
    Fazzi P; Manni E; Cristofani R; Cei G; Piazza S; Calabrese R; Antonelli A; Siciliano G; Barachini P; Carpi A
    Biomed Pharmacother; 2012 Jun; 66(4):300-7. PubMed ID: 22494798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
    Ordi-Ros J; Cortés F; Cucurull E; Mauri M; Buján S; Vilardell M
    J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case series of 48 patients treated with thalidomide.
    Doherty SD; Hsu S
    J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thalidomide therapy for discoid lupus erythematosus].
    Lyakhovisky A; Baum S; Shpiro D; Salomon M; Trau H
    Harefuah; 2006 Jul; 145(7):489-92, 551. PubMed ID: 16900736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis.
    Droitcourt C; Rybojad M; Porcher R; Juillard C; Cosnes A; Joly P; Lacour JP; D'Incan M; Dupin N; Sassolas B; Misery L; Chevrant-Breton J; Lebrun-Vignes B; Desseaux K; Valeyre D; Revuz J; Tazi A; Chosidow O; Dupuy A
    Chest; 2014 Oct; 146(4):1046-1054. PubMed ID: 24945194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment by thalidomide of chronic multiforme erythema: its recurrent and continuous variants. A retrospective study of 26 patients].
    Cherouati K; Claudy A; Souteyrand P; Cambazard F; Vaillant L; Moulin G; Crickx B; Morel P; Lamorelle A; Revuz J
    Ann Dermatol Venereol; 1996; 123(6-7):375-7. PubMed ID: 8959059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossover study of thalidomide vs placebo in Jessner's lymphocytic infiltration of the skin.
    Guillaume JC; Moulin G; Dieng MT; Poli F; Morel P; Souteyrand P; Bonnetblanc JM; Claudy A; Daniel F; Vaillant L
    Arch Dermatol; 1995 Sep; 131(9):1032-5. PubMed ID: 7661605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous sarcoidosis therapy updated.
    Badgwell C; Rosen T
    J Am Acad Dermatol; 2007 Jan; 56(1):69-83. PubMed ID: 17190623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
    Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
    Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis.
    Pignone AM; Rosso AD; Fiori G; Matucci-Cerinic M; Becucci A; Tempestini A; Livi R; Generini S; Gramigna L; Benvenuti C; Carossino AM; Conforti ML; Perfetto F
    J Pineal Res; 2006 Sep; 41(2):95-100. PubMed ID: 16879313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low-dose thalidomide in refractory and relapsing multiple myeloma].
    Radocha J; Maisnar V
    Vnitr Lek; 2007 Feb; 53(2):129-34. PubMed ID: 17419173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.
    Cortés-Hernández J; Torres-Salido M; Castro-Marrero J; Vilardell-Tarres M; Ordi-Ros J
    Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept for chronic progressive cutaneous sarcoidosis.
    Tuchinda C; Wong HK
    J Drugs Dermatol; 2006 Jun; 5(6):538-40. PubMed ID: 16774106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report.
    Lee JB; Koblenzer PS
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):835-8. PubMed ID: 9810910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of erosive oral lichen planus with thalidomide].
    Macario-Barrel A; Balguerie X; Joly P
    Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1109-12. PubMed ID: 14724512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus.
    Thomson KF; Goodfield MJ
    J Dermatolog Treat; 2001 Sep; 12(3):145-7. PubMed ID: 12243705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.